Conference abstractPublished 2018
Towards the treatment and prevention of invasive non-typhoidal Salmonella infections
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This lecture will address strategies to develop novel therapeutics against invasive non-typhoidal Salmonella infections. Salmonellosis is one of the most common foodborne diseases worldwide that causes a huge burden of morbidity and mortality in humans. Although non-typhoidal Salmonella serovars including Salmonella Typhimurium and Salmonella Dublin are associated primarily with self-limiting gastrointestinal illness they have adapted to cause invasive disease in humans particularly children, elderly and immunocompromised people. It is estimated that 680,000 people die every year as a result of infection by invasive non-typhoidal Salmonella. Interestingly, non-typhidal Salmonella have developed multi-drug resistance against current antibiotics including the last resource, colistin. Bacteriophage therapy is therefore the hope for the treatment of multidrug resistant infections however one of the key limitations to therapeutic use of phages, in particular for empiric therapy of infections, is the limited host range of many phages and the ease of development of bacterial resistance to phages. A solution may be to develop one or a cocktail of engineered phage that overcome some of these limitations. An essential step towards this goal is greater understanding of the complex dynamics of bacteriaphage interaction. We therefore use Anderson phage typing scheme of Salmonella Typhimurium as it provides a valuable model system for study of phage-host interaction and it will help us to characterize all bacterial antiviral systems and phage evasion strategies. The project will provide new insights into phage biology and strategies for genetic modification of phages and designing of effective broad spectrum engineered phages to overcome the limitations of bacteriophages as therapeutic agents. There is no vaccine against non-typhoidal Salmonella however our understanding of the molecular basis of virulence in invasive Salmonella Dublin using next generation sequencing technologies and associated bioinformatics associated tools will provide insights into the development of an effective vaccine through identification of novel virulence-attenuated strains with a potential for use as vaccine candidates for high-risk groups.
Subjects
MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Clinical Microbiology
- SubjectMicrobiology
- BylineArticles whose byline prints “Manal Mohammed”
